ABCG2 and hepatocellular carcinoma: This is consistent with past studies where activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds [37–38]; and the link between ABCG2 and resistance to chemotherapy in HCC [43].